Features
Innovative treatments for Non-Communicable Diseases (NCDs)
Non-Communicable Diseases (NCDs) are the leading cause of death and disability worldwide, accounting for over 74 per cent of global deaths.
The World Health Organisation (WHO) estimates that NCDs kill 41 million people each year, with 77 per cent of these deaths occurring in low and middle-income countries.
The growing burden of NCDs poses a significant threat to global health, economic growth, and development.
The EU’s EU4Health Programme: A game-changer in NCD management
The EU’s EU4Health programme is at the forefront of innovative NCD management, leveraging AI and health data to improve cardiovascular health and related NCDs. This initiative focuses on five key areas:
1. Risk prediction and prevention: Developing AI-powered tools to predict and prevent cardiovascular diseases and related NCDs.
2. Treatments: Improving access to innovative treatments and therapies for NCDs.
3. Personalised care: Enabling personalised care and rehabilitation for individuals with NCDs.
4. Health data: Structuring, federating, and enabling secure, high-quality, interoperable health data to support AI development and use.
5. Capacity building: Strengthening national and EU-level capacities to support the development and deployment of AI and health data for NCD management.
WHO’s Global Action Plan: A framework for NCD prevention and control
The WHO Global Action Plan for the prevention and control of NCDs 2013-2030 provides a framework for countries to reduce premature mortality and morbidity from NCDs. The plan aims to achieve a set of 9 global targets, including:
1. Reducing premature mortality from NCDs by 25 per cent by 2025.
2. Increasing access to essential medicines and technologies for NCDs.
3. Strengthening national health systems to respond to NCDs.
Innovative treatments for NCDs: A glimpse into the future
Some of the innovative treatments being explored for NCDs include:
1. Gene editing: Using gene editing technologies, such as Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR), to treat genetic disorders.
CRISPR is a system that bacteria use to defend against viruses, and scientists have adapted it for gene editing.
2. Stem cell therapy: Using stem cells to repair or replace damaged tissues.
3. Immunotherapy: Harnessing the power of the immune system to fight diseases.
4. Digital health interventions: Leveraging digital technologies, such as mobile apps and wearables, to support NCD management.
Conclusion
The growing burden of NCDs requires innovative and sustained efforts to prevent, manage, and treat these diseases. The EU’s EU4Health programme and the WHO’s Global Action Plan are important steps towards reducing the impact of NCDs.
As we move forward, it is essential to continue investing in research, innovation, and global cooperation to address the NCD epidemic.
Join our WhatsApp Channel now!
https://whatsapp.com/channel/0029VbBElzjInlqHhl1aTU27
